CompuMed Teams With The Jessica Clinton MVP Foundation for "Cardio Days"
March 14 2011 - 7:15AM
CompuMed, Inc. (OTCBB:CMPD)
(http://www.compumed.net), a telemedicine and medical informatics
company, has teamed up with Florida's The Jessica Clinton MVP
Foundation to provide CompuMed's electrocardiogram (ECG)
telemedicine and CardioGramKidsĀ® screenings to the students and
student athletes on "Cardio Days." CompuMed's CardioGramKids
program was designed in tandem with pediatricians and other
healthcare providers. It provides ECG screening services with
over-reads performed remotely by pediatric cardiologists to
children and teenagers prior to taking psychotropic medications or
participating in school or afterschool sports programs. The Jessica
Clinton MVP Foundation was formed in December 2003 by parents Ramon
& Cheryl Lalloo after losing their daughter Jessica to sudden
cardiac arrest while cheerleading.
"The Jessica Clinton MVP Foundation has done so much to help
save the lives of children in Florida. We have mutual goals of
bringing better health to children of all ages. Teaming up creates
a valuable partnership," said Maurizio Vecchione, CEO of
CompuMed.
"We'd focused successful efforts in getting defibrillators in
all schools in Florida but we realize it would be fantastic to find
the kids with heart problems before they need a
defibrillator. Teaming up with CompuMed to provide ECGs to
kids first makes perfect sense," said Cheryl Lalloo, the Founder of
The Jessica Clinton MVP Foundation.
"We plan to work with the Foundation to have a Cardio Day in the
city where Jessica died, and then encourage schools to do ECG
screening days as well," said Maurizio Vecchione, CEO of
CompuMed.
About CompuMed
CompuMed, Inc. (OTCBB:CMPD) develops and markets products and
services that combine advanced imaging with medical informatics.
Its focus is on analysis and remote monitoring for patients with
cardiovascular and musculoskeletal diseases. The company has
specialized expertise and intellectual property in telemonitoring
imaging and analysis designed to improve healthcare provider
workflow and patient care while reducing costs. CompuMed is
headquartered in Los Angeles and distributes its products worldwide
both directly and through OEM partners. Visit CompuMed at
www.compumed.net and follow at Twitter: @compumed.
The Jessica Clinton MVP Foundation
The Jessica Clinton MVP Foundation was formed in Dec. 2003,
co-founded by Ramon & Cheryl Lalloo, after the loss of their
daughter Jessica. On Oct. 2nd, 2003, while taking a break during
cheerleading practice, Jessica went into Sudden Cardiac Arrest.
Although CPR was performed, they were unable to resuscitate her.
Jessica had numerous sports physicals and was never diagnosed with
any heart conditions. It was discovered that Jessica had an
undiagnosed heart condition called Mitral Valve Prolapse. Since
then The Jessica Clinton MVP Foundation have been working with
local school boards to provide A.E.D.'s to the schools and develop
training programs for their faculty. The Foundation has directly
donated over 60 defibrillators to local schools and parks. The
Foundation has also participated in the deployment of hundreds of
defibrillators in the State of Florida. In addition, the Foundation
has provided CPR/AED training for hundreds of faculty members and
to the general public. In 2006, in a joint effort with the American
Heart Association, the Foundation successfully lobbied to have a
bill passed requiring all high schools in the State of Florida
which participate in an athletic program to have at least one
defibrillator on the premises. In 2007 The Foundation received the
"Jefferson Award" for public service. The Foundation is committed
in taking progressive steps to reduce the risk of losing our
children unnecessarily to Sudden Cardiac Arrest. More info at
www.jessicaclinton.org.
Forward-Looking Statements
Statements contained in this press release that are not
historical facts, such as statements about prospective earnings,
savings, revenue, operations, revenue and earnings growth, results
of contracts and other financial results, are forward-looking
statements pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. All such forward-looking
statements including statements concerning the Company's plans,
objectives, expectations and intentions are based largely on
management's expectations and are subject to and qualified by risks
and uncertainties that could cause actual results to differ
materially from those expressed or implied by such statements.
These statements are subject to uncertainties and risks including,
without limitation, competitive factors, outsourcing trends in the
pharmaceutical industry, product and service demand and acceptance,
changes in technology, ability to raise capital, the availability
of appropriate acquisition candidates and/or business partnerships,
economic conditions, the impact of competition and pricing,
capacity and supply constraints or difficulties, government
regulation and other risks identified in the Company's filings with
the Securities and Exchange Commission including its Annual Report
on Form 10-KSB and Quarterly Reports on Form 10-QSB. All such
forward-looking statements are expressly qualified by these
cautionary statements. The Company expressly disclaims any
obligation or undertaking to release publicly any updates or
revisions to any forward-looking statements to reflect events,
conditions or circumstances on which any such statement is based
after the date hereof, except as required by law.
CONTACT: Press Contact:
Susan Tellem
Tellem Worldwide
+1 310-313-3444
stellem@tellem.com
Common Stock (PK) (USOTC:CMPD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Common Stock (PK) (USOTC:CMPD)
Historical Stock Chart
From Sep 2023 to Sep 2024